Coya Therapeutics, Inc. (COYA)
Data as of , from SEC Form 4 filings.
See up to 3 months of COYA. The 7-day demo opens the 1M and 3M ranges and puts COYA on your watchlist.
Start 7-day demoLatest COYA insider trades
About Coya Therapeutics, Inc. (COYA)
Coya Therapeutics, Inc. files with the SEC under CIK 0001835022 and is classified as pharmaceutical preparations. It is grouped with Health Care companies on this site.
COYA Form 4 activity by transaction type, last 90 days
No Form 4 activity for COYA in the last 90 days.
COYA insider transactions (Form 4)
1615 Form 4 filings on record, the earliest from Nov 12, 2024, newest first.
| Date | Insider | Transaction | Security | Shares | Price | Value |
|---|---|---|---|---|---|---|
| Mark H. Pavao | Grant or award | Stock Option (right to buy) | 10,000 | $0.00 | - | |
| David S. Snyder - Officer | Grant or award | Stock Option (right to buy) | 140,041 | $0.00 | - | |
| Fred Grossman - Officer | Grant or award | Stock Option (right to buy) | 140,041 | $0.00 | - | |
| Howard Berman - Officer | Grant or award | Stock Option (right to buy) | 15,257 | $0.00 | - | |
| Arun Swaminathan - Officer | Grant or award | Stock Option (right to buy) | 293,983 | $0.00 | - | |
| Anabella Villalobos | Grant or award | Stock Option (right to buy) | 10,000 | $0.00 | - | |
| Dov A. Md Goldstein | Grant or award | Stock Option (right to buy) | 10,000 | $0.00 | - | |
| Dieter Weinand | Grant or award | Stock Option (right to buy) | 10,000 | $0.00 | - | |
| Grant or award | Stock Option (right to buy) | 10,000 | $0.00 | - | ||
| Ann Lee | Grant or award | Stock Option (right to buy) | 10,000 | $0.00 | - | |
| Dov A. Md Goldstein - Director | Option exercise | Common Stock, par value $0.0001 per share | 17,557 | $1.09 | $19K | |
| Dov A. Md Goldstein - Director | Option exercise | Stock Option (right to buy) | 17,557 | $0.00 | - | |
| David S. Snyder - Officer | Open-market purchase | Common Stock, par value $0.0001 per share | 1,800 | $7.19 | $13K | |
| Arun Swaminathan - Officer | Open-market purchase | Common Stock, par value $0.0001 per share | 5,000 | $7.36 | $37K | |
| Fred Grossman - Officer | Open-market purchase | Common Stock, par value $0.0001 per share | 2,710 | $7.37 | $20K | |
| Arun Swaminathan - Officer | Open-market purchase | Common Stock, par value $0.0001 per share | 5,000 | $7.34 | $37K |
COYA insider trading FAQ
What is the latest insider trade for COYA?
Coya Therapeutics, Inc. (COYA) has filed no insider reports in the last 90 days. The most recent on record is dated 2026-04-09. The full record for COYA runs to 15 Form 4 filings, the earliest from 2024-11-12. InsiderAlpha adds new Form 4, Form 144 and 8-K filings as they arrive from SEC EDGAR.
How many insiders are buying COYA stock?
No insider purchases of COYA were filed in the last 90 days. 4 purchases are on record for this company.
How many insiders are selling COYA stock?
No insider sales of COYA were filed in the last 90 days.
Where can I see COYA SEC filings (Form 4, 10-K, 10-Q, 8-K)?
This page collects COYA Form 4 insider transactions, Form 144 sale notices and 8-K filings in one place. Annual 10-K and quarterly 10-Q reports live on the company's SEC EDGAR page.
More Health Care companies with insider activity
Recent insider filings
10The EDGAR links open each original Form 4, so you can check any number on this page against the filing it came from.
- - Mark H. Pavao view on EDGAR
- - David S. Snyder view on EDGAR
- - Fred Grossman view on EDGAR
- - Howard Berman view on EDGAR
- - Arun Swaminathan view on EDGAR
- - Anabella Villalobos view on EDGAR
- - Dov A. Md Goldstein view on EDGAR
- - Dieter Weinand view on EDGAR
- - Wilbur L. Ross Jr. view on EDGAR
Related companies with recent insider activity
Learn more
- What the Form 4 transaction codes mean
- Grants, option exercises, gifts and tax withholding are not trades on the market. The codes say which is which.
- Insider activity in Health Care
- Where COYA's peers are being bought and sold.
- Every recent Form 4
- The market-wide feed, updated as filings arrive from SEC EDGAR.
Follow COYA with a 7-day demo
- COYA on your watchlist
- Every COYA Form 4 filing on record
- Up to 3 months of COYA price history
- The daily trading plan of ranked insider buys, on a delay, with the plan archive